Haorui, established in the year 1997, operates as a manufacturer and provider of APIs, pharmaceutical intermediates, veterinary products, and food additives. Furthermore, it aids international pharmaceutical firms in achieving domestic registration for their finished dosage forms to support their global expansion efforts. The company's array of USFDA approved products includes Flumazenil, Granisetron HCl, Granisetron Base, Docetaxel Anhydrous, Irinotecan HCl, and Dasatinib Monohydrate among others. Its headquarters is situated in Shenzhen, China, while it maintains four manufacturing sites in Hubei, Zhejiang, Jiangxi, and Henan. The Hubei facility is recognized for its USFDA and EU GMP approvals, specializing in the production of high potency and oncology materials within a dedicated oncology workshop, meeting OEB 5 material production standards. Haorui prides itself as a dependable partner for all your pharmaceutical needs.
Products & Services
Adapalene
Alfuzosin
Alprostadil
Amisulpride
Sites
Country
People's Republic of ChinaCity
Ezhou
Address
Gedian. CN, 436032
Country
People's Republic of ChinaAddress
CN-436070. HUBEI. China
Hubei Haosun Pharmaceutical
Country
People's Republic of ChinaAddress
Ju Xian Lu